Current Report Filing (8-k)
January 10 2023 - 06:46AM
Edgar (US Regulatory)
0000040545false00000405452023-01-102023-01-100000040545us-gaap:CommonStockMember2023-01-102023-01-100000040545ge:A1.250NotesDue2023Member2023-01-102023-01-100000040545ge:A0.875NotesDue2025Member2023-01-102023-01-100000040545ge:A1.875NotesDue2027Member2023-01-102023-01-100000040545ge:A1.500NotesDue2029Member2023-01-102023-01-100000040545ge:A7.5GuaranteedSubordinatedNotesDue2035Member2023-01-102023-01-100000040545ge:A2.125NotesDue2037Member2023-01-102023-01-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
January 10, 2023
General Electric Company
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New York |
|
001-00035 |
|
14-0689340 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
|
|
5 Necco Street |
Boston, |
MA |
|
|
|
02210 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
|
|
|
|
|
|
(Registrant’s telephone number, including area code)
(617) 443-3000
_______________________________________________
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instructions
A.2. below):
|
|
|
|
|
|
|
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, par value $0.01 per share
|
GE
|
New York Stock Exchange
|
1.250% Notes due 2023
|
GE 23E
|
New York Stock Exchange
|
0.875% Notes due 2025
|
GE 25
|
New York Stock Exchange
|
1.875% Notes due 2027
|
GE 27E
|
New York Stock Exchange
|
1.500% Notes due 2029
|
GE 29
|
New York Stock Exchange
|
7 1/2% Guaranteed Subordinated Notes due 2035
|
GE /35
|
New York Stock Exchange
|
2.125% Notes due 2037
|
GE 37
|
New York Stock Exchange
|
|
|
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§ 240.12b-2 of this chapter). |
|
|
Emerging growth company |
☐ |
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards pursuant to Section 13(a) of the Exchange
Act. |
☐ |
Item 2.02 Results of Operations and Financial
Condition.
On January 10, 2023, GE HealthCare Technologies Inc. (“GE
HealthCare”) issued a press release announcing, among other things,
preliminary unaudited financial results for GE HealthCare for the
fourth quarter and fiscal year ended December 31, 2022. A copy of
the press release is furnished as Exhibit 99 to this Current Report
on Form 8-K, which we are providing because GE HealthCare before
its separation from General Electric Company (“GE”) on January 3,
2023 was part of GE’s consolidated financial results. The
preliminary financial results provided do not present all
information necessary for a complete understanding of GE’s or GE
HealthCare’s earnings results for the fiscal year ended December
31, 2022. GE’s fourth-quarter and fiscal year 2022 earnings webcast
is scheduled for 8:00 a.m. EST on January 24, 2023.
The information provided pursuant to this Item 2.02, including
Exhibit 99, is being furnished and shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities under that
Section and shall not be deemed to be incorporated by reference
into any filing of the Company under the Securities Act of 1933 or
the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
|
|
Exhibit |
Description |
|
|
104 |
The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL. |
Forward-looking statements
This document contains “forward-looking statements”—that is,
statements related to future, not past, events. These
forward-looking statements often address GE’s expected future
business and financial performance and financial condition, and
often contain words such as “expect,” “anticipate,” “intend,”
“plan,” “believe,” “seek,” “see,” “will,” “would,” “estimate,”
“forecast,” “target,” “preliminary,” or “range.” Forward-looking
statements by their nature address matters that are, to different
degrees, uncertain, and are subject to risks, uncertainties and
assumptions. For GE, particular areas where risks or uncertainties
could cause GE’s actual results to be materially different than
those expressed in GE’s forward-looking statements include: GE’s
success in executing and completing asset dispositions or other
transactions, including GE’s plans to pursue the spin-off of its
portfolio of energy businesses that are planned to be combined as
GE Vernova (Renewable Energy, Power, Digital and Energy Financial
Services), and sales or other dispositions of GE’s equity interests
in AerCap Holdings N.V. and GE HealthCare, the timing for such
transactions, the ability to satisfy any applicable pre-conditions,
and the expected proceeds, consideration and benefits to GE;
changes in macroeconomic and market conditions and market
volatility, including impacts related to the COVID-19 pandemic,
risk of recession, inflation, supply chain constraints or
disruptions, rising interest rates, oil, natural gas and other
commodity prices and exchange rates, and the impact of such changes
and volatility on GE’s business operations, financial results and
financial position; and GE’s de-leveraging and capital allocation
plans, including with respect to actions to reduce its
indebtedness, the capital structures of the public companies that
GE plans to form from its businesses, the timing and amount of
dividends, share repurchases, organic investments, and other
priorities; and other factors that are described in the “Risk
Factors” section of GE’s Annual Report on Form 10-K for the year
ended December 31, 2021 and its Quarterly Report on Form 10-Q for
the quarter ended March 31, 2022, as such descriptions may be
updated or amended in any future reports that GE files with the
SEC. These or other uncertainties may cause GE’s actual future
results to be materially different than those expressed in its
forward-looking statements. GE does not undertake to update its
forward-looking statements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Electric Company |
|
|
|
(Registrant) |
|
|
|
|
|
Date: January 10, 2023
|
|
/s/ Thomas S. Timko |
|
|
|
Thomas S. Timko
Vice President, Chief Accounting Officer and
Controller
Principal Accounting Officer
|
|
General Electric (NYSE:GE)
Historical Stock Chart
From May 2023 to Jun 2023
General Electric (NYSE:GE)
Historical Stock Chart
From Jun 2022 to Jun 2023